| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 22,930 | 23,260 | 19:03 | |
| 22,880 | 23,100 | 21.02. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.02. | CVC und Gründerfamilie kommen auf 72 Prozent an Compugroup | ||
| 14.02. | EQS-News: CompuGroup Medical SE & Co. KGaA: Endgültiges Ergebnis des freiwilligen öffentlichen Übernahmeangebots - CVC sichert sich 21,85 % aller ausstehenden Aktien und Stimmrechte von CompuGroup Medical | EQS-News: CompuGroup Medical SE & Co. KGaA
/ Schlagwort(e): Übernahmeangebot
Endgültiges Ergebnis des freiwilligen öffentlichen Übernahmeangebots - CVC sichert sich 21,85 % aller... ► Artikel lesen | |
| 14.02. | CVC Capital Partners PLC: Full-Year Activity Update | Key Highlights
Full-Year 2024 Activity Update
• Total AUM reached €200bn as at 31 December 2024. FPAUM increased to €147bn, or +50% vs. €98bn as at 31 December 2023
• Continued recovery... ► Artikel lesen | |
| 10.02. | Piraeus targets 70% stake in CVC's Ethniki Insurance for €469m | ||
| 10.02. | CVC Capital Partners eyes Telecom Italia investment amid Poste interest |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.12.24 | Mallinckrodt plc - 8-K, Current Report | ||
| 02.12.24 | CVC Completes Acquisition of Therakos from Mallinckrodt | CVC, a leading global private markets manager, today completed the previously announced acquisition of the Therakos business from Mallinckrodt plc ("Mallinckrodt"), a global specialty pharmaceutical... ► Artikel lesen | |
| 18.11.24 | Mallinckrodt reports on HRS treatment study | ||
| 14.11.24 | Mallinckrodt plc: Mallinckrodt announces the 2024 Winner of the Extracorporeal Immunomodulation Award | This year's award marks 30 years since clinicians first used ECP to successfully treat chronic graft versus host disease (cGvHD).1 In recognition of this important milestone, this year's... ► Artikel lesen | |
| 05.11.24 | Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance | Achieves Third Quarter Net Sales of $505.5 Million, Reflecting 1.7% Year-Over-Year Growth
Reaffirms Full Year Net Sales Guidance and Raises Full Year Adjusted EBITDA... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| CVC CAPITAL PARTNERS PLC | 23,050 | +0,26 % |
| MALLINCKRODT PLC | - | - |
